These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 36727522)

  • 1. Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study.
    Sung KC; Yoo TK; Lee MY; Byrne CD; Zheng MH; Targher G
    Arterioscler Thromb Vasc Biol; 2023 Mar; 43(3):482-491. PubMed ID: 36727522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.
    Chang Y; Ryu S; Sung KC; Cho YK; Sung E; Kim HN; Jung HS; Yun KE; Ahn J; Shin H; Wild SH; Byrne CD
    Gut; 2019 Sep; 68(9):1667-1675. PubMed ID: 30472683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of MAFLD and NAFLD on arterial stiffness: A longitudinal cohort study.
    Yoo TK; Lee SW; Lee MY; Choi H; Sung KC
    Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1769-1778. PubMed ID: 38644081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study.
    Jung CY; Koh HB; Park KH; Joo YS; Kim HW; Ahn SH; Park JT; Kim SU
    Diabetes Metab; 2022 Jul; 48(4):101344. PubMed ID: 35346856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic Fatty Liver Disease Is Associated With Coronary Artery Calcification Development: A Longitudinal Study.
    Park HE; Kwak MS; Kim D; Kim MK; Cha MJ; Choi SY
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3134-43. PubMed ID: 27253666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease.
    Kang MK; Lee YR; Jang SY; Tak WY; Kweon YO; Song JE; Loomba R; Park SY; Park JG
    Hepatol Int; 2023 Jun; 17(3):626-635. PubMed ID: 37069419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification.
    Kang MK; Song JE; Loomba R; Park SY; Tak WY; Kweon YO; Lee YR; Park JG
    Sci Rep; 2024 Oct; 14(1):22917. PubMed ID: 39358447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification.
    Kang MK; Song J; Loomba R; Park S; Tak W; Kweon Y; Lee Y; Park JG
    Res Sq; 2024 Mar; ():. PubMed ID: 38496485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly.
    Jacobs K; Brouha S; Bettencourt R; Barrett-Connor E; Sirlin C; Loomba R
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1337-1344.e3. PubMed ID: 26820400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis.
    Bessho R; Kashiwagi K; Ikura A; Yamataka K; Inaishi J; Takaishi H; Kanai T
    PLoS One; 2022; 17(5):e0269265. PubMed ID: 35639744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease without overlapping metabolic-associated fatty liver disease and the risk of incident type 2 diabetes.
    Cho Y; Chang Y; Ryu S; Wild SH; Byrne CD
    Liver Int; 2023 Nov; 43(11):2445-2454. PubMed ID: 37387519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
    Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan.
    Yoneda M; Yamamoto T; Honda Y; Imajo K; Ogawa Y; Kessoku T; Kobayashi T; Nogami A; Higurashi T; Kato S; Hosono K; Saito S; Nakajima A
    J Gastroenterol; 2021 Nov; 56(11):1022-1032. PubMed ID: 34601620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.
    Liang Y; Chen H; Liu Y; Hou X; Wei L; Bao Y; Yang C; Zong G; Wu J; Jia W
    J Clin Endocrinol Metab; 2022 Jan; 107(1):88-97. PubMed ID: 34508601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups.
    Kim H; Lee CJ; Ahn SH; Lee KS; Lee BK; Baik SJ; Kim SU; Lee JI
    Dig Dis Sci; 2022 Oct; 67(10):4919-4928. PubMed ID: 35579799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome.
    Sinn DH; Kang D; Choi SC; Hong YS; Zhao D; Guallar E; Park Y; Cho J; Gwak GY
    Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1873-1880.e1. PubMed ID: 36152895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification.
    Cho YK; Kang YM; Yoo JH; Lee J; Lee SE; Yang DH; Kang JW; Park JY; Jung CH; Kim HK; Lee WJ
    Sci Rep; 2018 Aug; 8(1):12004. PubMed ID: 30104707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease is associated with coronary artery calcification.
    Kim D; Choi SY; Park EH; Lee W; Kang JH; Kim W; Kim YJ; Yoon JH; Jeong SH; Lee DH; Lee HS; Larson J; Therneau TM; Kim WR
    Hepatology; 2012 Aug; 56(2):605-13. PubMed ID: 22271511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women.
    Kim MK; Ahn CW; Nam JS; Kang S; Park JS; Kim KR
    Menopause; 2015 Dec; 22(12):1323-7. PubMed ID: 26154274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification in a Northern Chinese Population: a Cross Sectional Study.
    Wu R; Hou F; Wang X; Zhou Y; Sun K; Wang Y; Liu H; Wu J; Zhao R; Hu J
    Sci Rep; 2017 Aug; 7(1):9933. PubMed ID: 28855585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.